Steer clear of use of mixed agonist/antagonist (eg, pentazocine, nalbuphine, and butorphanol) or partial agonist (eg, buprenorphine) analgesics in clients that are receiving a complete opioid agonist analgesic; mixed agonist/antagonist and partial agonist analgesics may perhaps cut down analgesic effect and/or precipitate withdrawal signs or sympto… Read More